Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Hindustan Copper Reports 9% Rise in MIC Output for FY26
• SAIL Shares Slip 0.91% as CMD Amarendu Prakash Steps Down
• Bosch Jumps 12% in Two Sessions on E-Mobility JV
• Latent View Analytics Shares Skyrocket 20% on Deal with Healtheon AI 
• Ola Electric Shares Jump 9% on Roadster X+ Price Cut

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.